Placemark Investments’s AbbVie ABBV Stock Holding History

Placemark Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$8.05M	Buy	123,126 +8,484	+7%	+$535K	0.14%	180
2014 Q3	$6.63M	Sell	114,642 -8,357	-7%	-$464K	0.12%	207
2014 Q2	$6.95M	Buy	122,999 +13,951	+13%	+$732K	0.12%	206
2014 Q1	$5.61M	Sell	109,048 -150,833	-58%	-$7.62M	0.11%	218
2013 Q4	$13.7M	Buy	259,881 +28,760	+12%	+$1.41M	0.23%	96
2013 Q3	$10.3M	Sell	231,121 -16,048	-6%	-$711K	0.2%	122
2013 Q2	$10.2M	Buy	+247,169	New	+$10.8M	0.22%	110

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Placemark Investments's ABBV Position: Q4 2014 in Review

Placemark Investments increased its AbbVie (ABBV) stake by 7.4% in Q4 2014, buying an estimated $535K and bringing the position to 123,126 shares worth $8.05M. The position accounts for 0.14% of the portfolio, ranked #180.

Placemark Investments first reported a position in ABBV in Q2 2013 and has held it in 7 quarters since. The position peaked at $13.7M in Q4 2013. 1,604 funds tracked by Wall St. Rank hold ABBV as of Q4 2014.

Placemark Investments held 123,126 shares of AbbVie worth $8.05M as of Q4 2014.
Placemark Investments bought 8,484 AbbVie shares in Q4 2014, an estimated $535K.
AbbVie made up 0.14% of Placemark Investments's portfolio in Q4 2014, its #180 holding.
Placemark Investments first reported a position in AbbVie in Q2 2013 and has held it in 7 quarters since.
Placemark Investments's AbbVie position peaked at $13.7M in Q4 2013.
1,604 funds tracked by Wall St. Rank held AbbVie as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.